文献速递脑血管病外科

208例基底动脉尖动脉瘤血管内治疗与显微外科治疗的比较

Comparison of endovascular and microsurgical management of 208 basilar apex aneurysms.
PubMed 文献 · J Neurosurg · 2017-01-13

回顾性分析2000至2012年208例连续基底动脉尖动脉瘤患者,其中161例接受血管内治疗、47例接受显微外科治疗。显微外科组颅神经缺损和偏瘫并发症更多,血管内治疗组动脉瘤残留和需再治疗更多;两组再出血率及出院和1年GOS评分无统计学差异。作者认为经选择的患者中显微外科治疗仍起重要作用。

要点

  • 显微外科组颅神经缺损55.3% vs 血管内治疗组16.2%(p<0.05),偏瘫27.7% vs 10.6%(p<0.05)。
  • 血管内治疗组动脉瘤残留41.3% vs 显微外科组2.3%(p<0.05),需再治疗10.6% vs 0.0%(p<0.05)。
  • 两组出院时和1年平均GOS评分及再出血率无统计学差异。

核心结论

  • 基底动脉尖动脉瘤患者显著更倾向于接受血管内治疗,但与显微外科治疗相比,血管内治疗组复发率和需再治疗率更高。
  • 本研究未发现两种治疗方式在出院时和1年时总体结局存在差异。
  • 因此,在经选择的患者群体中,显微外科治疗仍起重要作用。

研究设计与样本

  • 回顾性分析2000至2012年间连续收治的208例基底动脉尖动脉瘤患者的前瞻性维护数据库。
  • 161例接受血管内治疗,47例接受显微外科治疗。
  • 比较就诊特征、术后并发症、出院状态及治疗后1年内的Glasgow结局量表(GOS)评分,采用卡方检验和Student t检验。

主要发现

  • 208个动脉瘤中116个(56%)为破裂动脉瘤,血管内治疗组92个(57%)、显微外科组24个(51%)。
  • 平均Hunt and Hess分级为2.4(血管内治疗组2.4,显微外科组2.2;p=0.472)。
  • 显微外科组颅神经缺损和偏瘫并发症较血管内治疗组更常见(分别为55.3% vs 16.2%,p<0.05;27.7% vs 10.6%,p<0.05)。
  • 血管内治疗组动脉瘤残留和需再治疗较显微外科组更常见(分别为41.3% vs 2.3%,p<0.05;10.6% vs 0.0%,p<0.05)。
  • 支架置入显著减少了再治疗需求。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE The deep and difficult-to-reach location of basilar apex aneurysms, along with their location near critical adjacent perforating arteries, has rendered the perception that microsurgical treatment of these aneurysms is risky. As a result, these aneurysms are considered more suitable for treatment by endovascular intervention. The authors attempt to compare the immediate and long-term outcomes of microsurgery versus endovascular therapy for this aneurysm subtype. METHODS A prospectively maintained database of 208 consecutive patients treated for basilar apex aneurysms between 2000 and 2012 was reviewed. In this group, 161 patients underwent endovascular treatment and 47 were managed microsurgically. The corresponding records were analyzed for presenting characteristics, postoperative complications, discharge status, and Glasgow Outcome Scale (GOS) scores up to 1 year after treatment and compared using chi-square and Student t-tests. RESULTS Among these 208 aneurysms, 116 (56%) were ruptured, including 92 (57%) and 24 (51%) of the endovascularly and microsurgically managed aneurysms, respectively. The average Hunt and Hess grade was 2.4 (2.4 in the endovascular group and 2.2 in the microsurgical group; p = 0.472). Postoperative complications of cranial nerve deficits and hemiparesis were more common in patients treated microsurgically than endovascularly (55.3% vs 16.2%, p < 0.05; and 27.7% vs 10.6%, p < 0.05, respectively). However, aneurysm remnants and need for retreatment were more common in the endovascular than the microsurgical group (41.3% vs 2.3%, p < 0.05; and 10.6% vs 0.0%, p < 0.05, respectively). Stent placement significantly reduced the need for retreatment. Rehemorrhage rates and average GOS score at discharge and 1 year after treatment were not statistically different between the two treatment groups. CONCLUSIONS Patients with basilar apex aneurysms were significantly more likely to be treated via endovascular management, but compared with those treated microsurgically, they had higher rates of recurrence and need for retreatment. The current study did not detect an overall difference in outcomes at discharge and 1 year after either treatment modality. Therefore, in a select group of patients, microsurgical treatment continues to play an important role.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bohnstedt BN, Ziemba-Davis M, Sethia R, et al. Comparison of endovascular and microsurgical management of 208 basilar apex aneurysms. J Neurosurg. 2017. PMID: 28084909. doi:10.3171/2016.8.JNS16703

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。